Clinical Trials · NCT00747968
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- University of Aarhus
- Enrollment
- 8
- Start date
- Feb 2010
- Locations
- 4 sites, Denmark
- Primary endpoint
- steady glucose metabolism in the heart and brain during hyperglycemia with GLP-1-analogue infusion compared to placebo.